BellRing Brands Files Q1 FY25 10-Q
Ticker: BRBR · Form: 10-Q · Filed: Feb 4, 2025 · CIK: 1772016
| Field | Detail |
|---|---|
| Company | Bellring Brands, INC. (BRBR) |
| Form Type | 10-Q |
| Filed Date | Feb 4, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
BellRing Brands Q1 FY25 10-Q is in. Check financials.
AI Summary
BellRing Brands, Inc. filed its 10-Q for the period ending December 31, 2024. The company reported financial results for the first quarter of fiscal year 2025. Key financial data and balance sheet information were disclosed in this filing.
Why It Matters
This filing provides investors with the latest financial performance and position of BellRing Brands, Inc., crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.
Key Players & Entities
- BELLRING BRANDS, INC. (company) — Filer
- 2024-12-31 (date) — Period of Report
- 2025-02-04 (date) — Filing Date
- 2024-10-01 (date) — Quarter Start Date
- 2023-10-01 (date) — Prior Year Quarter Start Date
FAQ
What were BellRing Brands' total assets as of December 31, 2024?
The filing indicates BellRing Brands' total assets were $3,677,700,000 as of December 31, 2024.
What was the company's retained earnings balance on September 30, 2024?
As of September 30, 2024, BellRing Brands' retained earnings were $738,700,000.
How much common stock did BellRing Brands have issued as of December 31, 2023?
BellRing Brands had $1,000 in common stock issued as of December 31, 2023.
What is the fiscal year end for BellRing Brands?
BellRing Brands' fiscal year ends on September 30.
What is the SEC file number for BellRing Brands?
The SEC file number for BellRing Brands is 001-39093.
Filing Stats: 4,620 words · 18 min read · ~15 pages · Grade level 9 · Accepted 2025-02-04 12:27:25
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share BRBR New York Stock
Filing Documents
- brbr-20241231.htm (10-Q) — 527KB
- brbrq12025ex311.htm (EX-31.1) — 11KB
- brbrq12025ex312.htm (EX-31.2) — 11KB
- brbrq12025ex321.htm (EX-32.1) — 15KB
- brbr-20241231_g1.jpg (GRAPHIC) — 15KB
- 0001772016-25-000028.txt ( ) — 3355KB
- brbr-20241231.xsd (EX-101.SCH) — 24KB
- brbr-20241231_cal.xml (EX-101.CAL) — 44KB
- brbr-20241231_def.xml (EX-101.DEF) — 78KB
- brbr-20241231_lab.xml (EX-101.LAB) — 347KB
- brbr-20241231_pre.xml (EX-101.PRE) — 226KB
- brbr-20241231_htm.xml (XML) — 306KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements (Unaudited)
Item 1. Financial Statements (Unaudited) 1 Condensed Consolidated Statements of Operations (Unaudited) 1 Condensed Consolidated Statements of Comprehensive Income (Unaudited) 2 Condensed Consolidated Balance Sheets (Unaudited) 3 Condensed Consolidated Statements of Cash Flows (Unaudited) 4 Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) 5 Notes to Condensed Consolidated Financial Statements (Unaudited) 6
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 13
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 17
Controls and Procedures
Item 4. Controls and Procedures 18
OTHER INFORMATION
PART II. OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 19
Risk Factors
Item 1A. Risk Factors 19
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 19
Other Information
Item 5. Other Information 19
Exhibits
Item 6. Exhibits 20
SIGNATURES
SIGNATURES 21 i Table of Contents
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION.
FINANCIAL STATEMENTS (UNAUDITED)
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED). BELLRING BRANDS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (in millions, except per share data) Three Months Ended December 31, 2024 2023 Net Sales $ 532.9 $ 430.4 Cost of goods sold 333.3 282.4 Gross Profit 199.6 148.0 Selling, general and administrative expenses 80.1 52.8 Amortization of intangible assets 4.2 22.2 Operating Profit 115.3 73.0 Interest expense, net 14.4 14.9 Earnings before Income Taxes 100.9 58.1 Income tax expense 24.0 14.2 Net Earnings $ 76.9 $ 43.9 Earnings per Common Share: Basic $ 0.60 $ 0.33 Diluted $ 0.59 $ 0.33 Weighted-Average Common Shares Outstanding: Basic 128.9 131.2 Diluted 131.1 133.0 See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited). 1 Table of Contents BELLRING BRANDS, INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (in millions) Three Months Ended December 31, 2024 2023 Net Earnings $ 76.9 $ 43.9 Unrealized foreign currency translation adjustments ( 1.4 ) 0.8 Other Comprehensive (Loss) Income ( 1.4 ) 0.8 Total Comprehensive Income $ 75.5 $ 44.7 See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited). 2 Table of Contents BELLRING BRANDS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions) December 31, 2024 September 30, 2024 ASSETS Current Assets Cash and cash equivalents $ 49.6 $ 71.1 Receivables, net 220.4 220.4 Inventories 348.9 286.1 Prepaid expenses and other current assets 30.6 15.1 Total Current Assets 649.5 592.7 Property, net 9.6 9.2 Goodwill 65.9 65.9 Intangible assets, net 137.6 141.8 Deferred income taxes 9.2 12.9 Other assets 13.4 14.5 Total Assets $ 885.2 $ 837.0 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable $ 110.9 $ 121.0 Other current liabilities 83.0 82.7 Total Current Liabilities 193.9 203.7 Long-term debt 833.4 833.1 Deferred income tax
Legal Proceedings
Legal Proceedings Joint Juice Litigation In March 2013, a complaint was filed on behalf of a putative, nationwide class of consumers against Premier Nutrition in the U.S. District Court for the Northern District of California seeking monetary damages and injunctive relief. The case asserted that some of Premier Nutrition's advertising claims regarding its Joint Juice line of glucosamine and chondroitin dietary supplement beverages, which it discontinued in the first quarter of fiscal 2023, were false and misleading. In April 2016, the district court certified a California-only class of consumers in this lawsuit (this lawsuit is hereinafter referred to as the "California Federal Class Lawsuit"). In 2016 and 2017, the lead plaintiff's counsel in the California Federal Class Lawsuit filed ten additional class action complaints in the U.S. District Court for the Northern District of California on behalf of putative classes of consumers under the laws of Connecticut, Florida, Illinois, New Jersey, New Mexico, New York, Maryland, Massachusetts, Michigan and Pennsylvania (the "Related Federal Actions"). These complaints contain factual allegations similar to the California Federal Class Lawsuit, also seeking monetary damages and injunctive relief. The action on behalf of New Jersey consumers was voluntarily dismissed. Trial in the action on behalf of New York consumers (the "New York Case") was held beginning in May 2022, and the jury delivered its verdict in favor of plaintiff in June 2022. In August 2022, the Court entered a judgment in that case in favor of plaintiff in the amount of $ 12.9 , which includes statutory damages and prejudgment interest, and in August 2023, the Court entered a judgment awarding plaintiff $ 7.9 in attorney's fees and costs. In October 2022, each plaintiff and Premier Nutrition filed Notices of Appeal to the Ninth Circuit on the damages award and in December 2023 Premier Nutrition filed its Notice of Appeal to the Ninth Circuit on the atto